VIOL Co., Ltd.

Equities

A335890

KR7335890000

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
9,890 ^KRW	+2.38%		-1.49%	+16.35%

Mar. 25	Sihuan Pharmaceutical's RF Device Wins Registration Approval in China	MT
2023	SULLIVAN WILL DISCUSS EFFORTS TO REIN IN 'EXTREMIST SETTLER VIOL…	RE

Tranche Update on VIOL Co., Ltd.'s Equity Buyback Plan announced on November 11, 2022.

May 15, 2023 at 02:32 am EDT

From April 1, 2023 to May 13, 2023, the company has repurchased 276,164 shares, representing 0.47% for KRW 1,446.38 million. With this, the company has completed the repurchase of 676,164 shares, representing 1.16% for KRW 2,999.9 million under the buyback announced on November 11, 2022.

Latest news about VIOL Co., Ltd.

Sihuan Pharmaceutical's RF Device Wins Registration Approval in China	Mar. 25	MT
SULLIVAN WILL DISCUSS EFFORTS TO REIN IN 'EXTREMIST SETTLER VIOL…	Dec. 14	RE
SPOKESMAN OF YEMEN'S HOUTHI GROUP: WE CONSIDER INCIDENTS OF VIOL…	23-09-26	RE
VIOL Co., Ltd.(KOSDAQ:A335890) added to S&P Global BMI Index	23-09-18	CI
Tranche Update on VIOL Co., Ltd.'s Equity Buyback Plan announced on November 11, 2022.	23-05-15	CI
Tranche Update on VIOL Co., Ltd.'s Equity Buyback Plan announced on November 11, 2022.	23-05-15	CI
VIOL Co., Ltd.'s Equity Buyback announced on November 11, 2022, has expired with 676,164 shares, representing 1.16% for KRW 2,999.9 million.	23-05-12	CI
VIOL Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
UAW PRESIDENT: STELLANTIS ILLINOIS PLANT IDLING A "FLAT OUT VIOL…	23-04-21	RE
Tranche Update on VIOL Co., Ltd.'s Equity Buyback Plan announced on November 11, 2022.	23-02-14	CI
VIOL Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.	22-11-10	CI
VIOL Co., Ltd. authorizes a Buyback Plan.	22-11-10	CI
Viol Co., Ltd. completed the acquisition of IBKS No.11 Special Purpose Acquisition Company from a group of shareholders in a reverse merger transaction.	20-11-10	CI
Viol Co., Ltd. entered into a contract to acquire IBKS No.11 Special Purpose Acquisition Company from a group of shareholders in a reverse merger transaction for approximately KRW 100 billion.	20-05-10	CI
DMS Co.,Ltd. agreed to acquire 30% stake in Viol for KRW 12 billion.	19-10-14	CI
Korea No.4 Special Purpose Acquisition Co., Ltd. cancelled the acquisition of Viol Co., Ltd. for KRW 54.3 billion.	18-07-23	CI
Orea No.4 Special Purpose Acquisition Co., Ltd. agreed to acquire Viol Co., Ltd. for KRW 54.3 billion.	18-05-02	CI

Chart VIOL Co., Ltd.

Duration

Period

More charts

Company Profile

Viol Co Ltd, formerly IBKS No.11 Special Purpose Acquisition Co, is a Korea-based company mainly engaged in the manufacture and sale of medical devices for skin beauty. The Company's main product is Scarlet, an equipment for elasticity and lifting. In addition, the Company develops and produces medical devices for anti-aging skin care. The Company sells its products in domestic and overseas markets such as China and the United States.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-09 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for VIOL Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9,890 KRW

Average target price

11,500 KRW

Spread / Average Target

+16.28%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
VIOL CO., LTD.	+16.35%	415M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology